Table of Contents
- What is Venetoclax, and what types of cancer does it treat?
- When and where was Venetoclax first discovered?
In this study, 78% of the subjects (almost 19 patients) remained Cancer free for at least 15 months after their treatment was complete.
Onco team remarks on these results, were very promising. “It’s unprecedented that we’re seeing such deep responses in a such a high proportion of patients. These drugs will almost certainly replace chemotherapy going forward. It could be game-changing if these responses are durable.”
References:
- NEJM – https://www.nejm.org/doi/full/10.1056/NEJMoa1713976
- Wikipedia – https://en.wikipedia.org/wiki/Venetoclax